Moreover, our results also showed that glabridin alleviated hyperglycemia-induced bone loss and osteoblast cell apoptosis by modulating the expression of the Akt/NF-ĸB and Akt/GSK-3β pathways. The gene discussed is AKT1; the disease is Hyperglycemia.